EMPAGLIFLOZIN (PROCESS II)

UPADACITINIB INTERMEDIATE 1 - TERT-BUTYL (5-TOSYL-5H-PYRROLO[2,3-B]PYRAZIN-2-YL) CARBAMATE

CYCLIC OLEFIN POLYMER PREFILLABLE SYRINGE

SILICONE OIL FREE CYCLIC OLEFIN POLYMER PREFILLABLE SYRINGE

SILICON DIOXIDE

NINTEDANIB ESYLATE

MSC SERUM FREE MEDIUM (GMP GRADE)

NK CELLS SERUM FREE MEDIUM (rHSA)

MYCOPHENOLATE SODIUM

FOSAPREPITANT DIMEGLUMINE

MANGANESE SULFATE

CUPRIC SULFATE

VALGANCICLOVIR HCL CRYSTALLINE TYPE II

QUETIAPINE FUMARATE USP (PROCESS II)

APREMILAST

APIXABAN

T7 RNA POLYMERASE

HYPROMELLOSE ACETATE SUCCINATE USP

TAURINE USP

INNOMEDIA� CELL CULTURE MEDIA

FEDRATINIB HYDROCHLORIDE

TAZOBACTAM

TESTOSTERONE TRIDECANOATE

RECOMBINANT HUMAN IL-1 / BETA IL1B PROTEIN

4-(4-Methoxyphenyl)-1,3-thiazol-2-amine

C10H10N2OS

LOSARTAN POTASSIUM USP

MONSTER ASSEMBLY

ADENOSINE-5'-TRIPHOSPHATE, TRISODIUM SALT (100mM)

EDOXABAN TOSYLATE MONOHYDRATE

GEMIFLOXACIN MESYLATE USP

LAMINATED FILMS (PET/AL) FOR PHARMACEUTICAL PACKAGING

EMPAGLIFLOZIN AMORPHOUS (PRODUCT CODE: EGF9)